After significant growth over the past year, Jordan's Aumet saw the time as ripe for independent operations.
Jordan-based business-to-business (B2B) healthcare marketplace, Aumet, has announced that their business spin-off, OnEx, is being established as a stand-alone startup, and will be kick-started with six-figure investments from Aumet.
OnEx aids medical manufacturers around the world in exporting their products to new markets by connecting them with potential distributors. Meanwhile, Aumet is the first marketplace platform which sells small and medium-sized businesses’ (SMEs) medical manufacturing products directly to healthcare providers.
Having operated as an Aumet subsidiary since 2015, OnEx’s new stand-alone status will enable both startups to grow independently to focus on their specific services.
With the decision came the assignment of Aumet co-founders, Mohammad Issa and Jamal Samra, as the new Co-Founders to lead OnEx. Aumet CEO Yahya Aqel will continue leading Aumet, and assures that the stand-alone status is an empowerment-enabler for both companies, rather than a separation.
After Aumet raised $1.25 million in seed funding in 2020, and secured a further six-figure pre-Series A investment in March, 2021, the time was seen as ripe for establishing autonomous operations.
Issa explained that “after the huge growth we saw from OnEx in the past year, it gave us the courage to provide OnEx the independence it needs, allowing us to unlock more potential for both businesses as a whole.”
Samra added that “the healthcare industry has proven to be one of the largest industries worldwide, especially after the pandemic, and with the help of technologies embedded in our product, OnEx can disrupt the whole supply chain industry on a global scale in no time.”